<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Obstetric complications such as fetal <z:hpo ids='HP_0011420'>death</z:hpo>, <z:hpo ids='HP_0001622'>premature delivery</z:hpo>, <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e> and <z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">recurrent abortions</z:e> (since chromosomal or anatomic defects have been excluded) are characteristic manifestations of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="1" pm="."><plain>They can occur in patients with known APS with previous arterial or venous events in any tissue or organ, or be its first and only manifestation </plain></SENT>
<SENT sid="2" pm="."><plain>Pregnancy in a patient with APS is considered high risk and the full prenatal clinical follow-up must be carried with this in mind, eliminating or minimizing concomitant thrombotic risk factors </plain></SENT>
</text></document>